Antineoplastic Combined Chemotherapy Protocols/pharmacology; Astrocytes/drug effects; Brain Neoplasms/pathology; Breast Neoplasms/pathology; Fibroblasts/drug effects; Glioblastoma/pathology; Myocytes, Cardiac/drug effects; Angiogenic Proteins/metabolism; Animals; Antibodies/pharmacology; Antineoplastic Combined Chemotherapy Protocols/toxicity; Astrocytes/pathology; Brain Neoplasms/enzymology; Breast Neoplasms/enzymology; Breast Neoplasms/immunology; Butyrates/pharmacology; Cell Line, Tumor; Cell Survival/drug effects; Cytoprotection; Dose-Response Relationship, Drug; Doxorubicin/pharmacology; Drug Synergism; Female; Fibroblasts/pathology; Glioblastoma/enzymology; Histone Deacetylase Inhibitors/pharmacology; Humans; Inflammation Mediators/metabolism; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Myocytes, Cardiac/pathology; Organophosphorus Compounds/pharmacology; Rats; Reactive Oxygen Species/metabolism; Receptor, ErbB-2/immunology; Time Factors